The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBiopharma Cred. Regulatory News (BPCR)

Share Price Information for Biopharma Cred. (BPCR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.876
Bid: 0.876
Ask: 0.878
Change: -0.004 (-0.45%)
Spread: 0.002 (0.228%)
Open: 0.882
High: 0.882
Low: 0.876
Prev. Close: 0.88
BPCR Live PriceLast checked at -
BioPharma Credit is an Investment Trust

To generate long-term shareholder returns, predominantly in the form of sustainable income distributions from exposure to the life sciences industry.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

27 Mar 2024 16:48

RNS Number : 5767I
BioPharma Credit PLC
27 March 2024
 

BIOPHARMA CREDIT PLC

 

Notification of Transactions by

Persons Discharging Managerial Responsibilities and

Persons Closely Associated with them

 

1.

Details of person discharging managerial responsibilities/person closely associated with them

a)

Name

Sapna Shah

2.

Reason for the notification

a)

Position / status

Director of BioPharma Credit PLC

b)

Initial notification / amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

BioPharma Credit PLC

b)

LEI

213800AV55PYXAS7SY24

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

 

Identification Code

Ordinary Shares of $0.01 each

 

 

GB00BDGKMY29

b)

Nature of the transaction

Purchase of Shares

c)

Price(s) and volume(s)

Price(s)

Volume(s)

£0.71511

20,000

d)

Aggregated information

- Aggregated volume

 

- Price

 

 

N/A

 

 

e)

Date of the transaction

27.03.2024

f)

Place of the transaction

London Stock Exchange (XLON)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBLGDXISDDGSR
Date   Source Headline
3rd Oct 20226:15 pmRNSTransaction in Own Shares
3rd Oct 20227:00 amRNSTotal Voting Rights
30th Sep 20226:15 pmRNSTransaction in Own Shares
29th Sep 20226:15 pmRNSTransaction in Own Shares
28th Sep 20226:15 pmRNSTransaction in Own Shares
27th Sep 20226:15 pmRNSTransaction in Own Shares
26th Sep 20226:15 pmRNSTransaction in Own Shares
23rd Sep 20226:15 pmRNSTransaction in Own Shares
22nd Sep 20226:15 pmRNSTransaction in Own Shares
22nd Sep 20224:00 pmRNSNet Asset Value(s) and Monthly Factsheet
20th Sep 20226:15 pmRNSTransaction in Own Shares
16th Sep 20226:15 pmRNSTransaction in Own Shares
15th Sep 20226:15 pmRNSTransaction in Own Shares
14th Sep 20227:00 amRNSHalf-yearly Report
14th Sep 20227:00 amRNSSTATEMENT RE SAREPTA THERAPEUTICS, INC.
31st Aug 20227:00 amRNSNotice of Half Year Results
22nd Aug 20224:53 pmRNSStatement re Epizyme
19th Aug 20224:00 pmRNSNet Asset Value(s) and Monthly Factsheet
16th Aug 20227:00 amRNSDividend Declaration
9th Aug 20227:00 amRNSSTATEMENT RE GLOBAL BLOOD THERAPEUTICS
21st Jul 20224:00 pmRNSNet Asset Value(s) and Monthly Factsheet
20th Jul 202211:11 amRNSStatement Re Akebia
11th Jul 20227:00 amRNSTransaction in Own Shares
8th Jul 20227:00 amRNSTransaction in Own Shares
6th Jul 20225:36 pmRNSTransaction in Own Shares
5th Jul 20225:40 pmRNSTransaction in Own Shares
1st Jul 20227:00 amRNSSHARE BUY-BACK PROGRAMME
28th Jun 20227:00 amRNSSTATEMENT RE EPIZYME
23rd Jun 20224:00 pmRNSNet Asset Value(s) and Monthly Factsheet
9th Jun 20225:39 pmRNSResult of AGM
23rd May 20224:00 pmRNSNet Asset Value(s) and Monthly Factsheet
13th May 202212:35 pmRNSNotice of AGM
5th May 202210:25 amRNSDirector/PDMR Shareholding
27th Apr 20225:15 pmRNSDividend Declaration
26th Apr 202211:36 amRNSHolding(s) in Company
25th Apr 20224:00 pmRNSNet Asset Value(s) and Monthly Factsheet
21st Apr 20223:18 pmRNSResults of Placing in BioPharma Credit Plc
20th Apr 20227:00 amRNSProposed Secondary Placing in BioPharma Credit Plc
22nd Mar 20227:00 amRNSAnnual Financial Report
21st Mar 20224:00 pmRNSNet Asset Value(s) and Monthly Factsheet
10th Mar 20222:17 pmRNSNOTICE OF FULL YEAR RESULTS
8th Mar 20224:30 pmRNSNEW INVESTMENT
24th Feb 20223:58 pmRNSDividend Declaration
21st Feb 20224:00 pmRNSNet Asset Value(s) and Monthly Factsheet
18th Feb 20224:37 pmRNSDirector/PDMR Shareholding
14th Feb 202212:30 pmRNSUS$325 MILLION INVESTMENT IN COLLEGIUM
24th Jan 20224:00 pmRNSNet Asset Value(s) and Monthly Factsheet
10th Jan 20227:00 amRNSNEW INVESTMENT OF UP TO US$150.0 MILLION
21st Dec 20214:00 pmRNSNet Asset Value(s) and Monthly Factsheet
15th Dec 20217:00 amRNSNEW INVESTMENTS OF UP TO US$112.5 MILLION

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.